A noninvasive method of measuring Max(dP/dt) of the left ventricle by Doppler echocardiography.
Although slightly affected by alterations in preload, the maximum first derivative of left ventricular pressure with respect to time, Max(dP/dt), is widely regarded as a simple and convenient index of cardiac contractility for clinical use. The feasibility of noninvasive, hence repeatable, measurement of Max(dP/dt) will certainly lead to re-evaluation of its usefulness. Max(dP/dt) is given by the following equation: Max(dP/dt) = rho c Max(du/dt), where rho is the blood density, c the pulse wave velocity, and mu the flow velocity in the aorta. This equation has been previously validated in animal experiments and has now been applied to the clinical setting for the first time. In 20 patients without aortic stenosis, left ventricular pressure was measured with a catheter-tip micromanometer, aortic ejection flow velocity was measured by Doppler echocardiography, and pulse wave velocity by mechanocardiography or Doppler echocardiography. Then, delta c Max (du/dt was calculated from the measured data and compared with measured Max (dP/dt). A significant positive correlation was found between them (rho c Max (du/dt) = 0.96 x Max (dP/dt) + 6.52, r = 0.83, p < 0.001). In 11 patients with hypertension, rho c Max (du/dt) was obtained before and after long-term (average 13.1 months) treatment with antihypertensive drugs. In spite of the expected reduction in blood pressure and the regression of left ventricular mass, rho c Max (du/dt) remaioned unchanged. In 9 patients with dilated cardiomyopathy, the effects of beta 1-agonist were tested at the beginning of therapy (30 mg/day denopamine) and 6 months later. The increase in rho c Max (du/dt) observed 1 hour after oral administration of he drug had not changed significantly 6 months later. We conclude that the index rho c Max (du/dt), is useful in assessing the contractile state of the left ventricle noninvasively.
Senda
S
S
2nd Department of Internal Medicine, Kagawa Medical School, Japan.
Sugawara
M
M
Matsumoto
Y
Y
Kan
T
T
Matsuo
H
H
D000959:Antihypertensive Agents / Q000494:pharmacology; D001783:Blood Flow Velocity; D001794:Blood Pressure; D002316:Cardiotonic Agents / Q000494:pharmacology; D015150:Echocardiography, Doppler / Q000295:instrumentation / Q000379:methods / Q000592:standards*; D005069:Evaluation Studies as Topic; D006352:Heart Ventricles / Q000000981:diagnostic imaging / Q000187:drug effects; D006801:Humans; D009200:Myocardial Contraction; D015588:Observer Variation; D011673:Pulsatile Flow; D015203:Reproducibility of Results; D013318:Stroke Volume; D016276:Ventricular Function
D000959:Antihypertensive Agents; D002316:Cardiotonic Agents